Developmental renal pathology: Its past, present, and future

Fetal and Pediatric Pathology

Volumn 23, Issue 4, 2004, Pages 211-229

  Rodriguez, Maria M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetic embryopathy; Pharmacogenetics; Polycystic kidneys; Post natal renal development; Renal agenesis; Renal dysplasia

Indexed keywords

AUTOSOMAL RECESSIVE DISORDER; CONGENITAL DISORDER; DIAGNOSTIC TEST; ECHOGRAPHY; EMBRYOLOGY; EMBRYOPATHY; HUMAN; HYDRONEPHROSIS; KIDNEY AGENESIS; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; MOLECULAR BIOLOGY; OLIGOHYDRAMNIOS; PERINATAL PERIOD; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; VESICOURETERAL REFLUX; CHILD; FETUS; KIDNEY; KIDNEY DISEASE; PATHOLOGY; PRENATAL DEVELOPMENT; URINARY TRACT; URINARY TRACT DISEASE;

CHILD; FETUS; HUMANS; KIDNEY; KIDNEY DISEASES; URINARY TRACT; UROLOGIC DISEASES;

EID: 24044470028     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.1080/15227950490923453     Document Type: Review

References (61)

1. Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A. Chronic renal insufficiency in children: the 2001 annual report of the NAPRTCS. Pediatr Nephrol 2003;18:796-804.
2. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106:659-671.
3. Chevalier RL. Effects of ureteral obstruction on renal growth. Semin Nephrol 1995;15:353-360.
4. Sadler TW. Urogenital system. In eds. Langman's Medical Embryology. Baltimore: Williams & Wilkins, 1990, p.260.
5. Shah MM, Sampogna V, Sakurai H, Bush KT, Nigam SK. Branching morphogenesis and kidney disease. Development 2004;131:1443-1462.
6. Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994;16:75-112.
7. Potter EL. Facial characteristics of infants with bilateral renal agenesis. Am J Obstet Gynecol 1946;41:885-888.
8. Gilbert-Barness E. Renal system. In Gilbert-Barness E., ed. Potter's Pathology of the Fetus and Infant. St. Louis, MO: Mosby year book, 1997, p.868.
9. Torres M, Gomez-Pardo E, Dressler Gr, Gruss P. Pax-2 controls multiple steps of urogenital development. Development 1995;121:4057-4065.
10. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. WT-1 is required for early kidney development. Cell 1993;74:679-691.
11. Schwarz RD, Stephens FD, Gussen LJ. The pathogenesis of renal dysplasia II. The significance of lateral and medial ectopy of the ureteric orifice. Invest Urol 1981;19:97-100.
12. Vermillion CD, Heale WF. Position and configuration of the ureteral orifice and its relationship to renal scarring in adults. J Urol 1973;109:579-584.
13. Yang SP, Woolf AS, Yuan HT, Scott RJ, Risdon RA, O'Hare MJ, Winyard PJ. Potential biological role of transforming growth factor-β1 in human congenital kidney malformations. Am J Pathol 2000;157:1633-1647.
14. Gasser B, Mauss Y, Ghnassia JP, Kohler M, Yu O, Vonesch JL. A quantitative study of normal nephrogenesis in the human fetus: its implications in the natural history of kidney changes due to low obstructive uropathies. Fetal Diagn Ther 1993;8:371-384.
15. Beharrie A, Franc-Guimond J, Rodriguez MM, Au J, Zilleruelo G, Abitbol CL. A functional immature model of chronic partial ureteral obstruction. Kidney Int 2004;65:1155-1161.
16. Wilson RD, Johnson MP. Prenatal ultrasound guided percutaneous shunts for obstructive uropathy and thoracic disease. Semin Pediatr Surg 2003;12:182-189.
17. Buchta RM, Viseskul C, Gilbert EF, Sarto GE, Opitz JM. Familial bilateral renal agenesis and hereditary renal adysplasia. Z Kinderheilkd 1973;115:111-129.
18. Moerman P, Fryns JP, Sastrowijoto SH, Vandenberghe K, Lauweryns JM. Hereditary renal adysplasia: new observations and hypotheses. Pediatr Pathol 1994;4:405-410.
19. Roodhoof AM, Birnholtz JC, Holmes LB. Familial nature of congenital absence and severe dysgenesis of both kidneys. N Engl J Med 1984;310:1341-1345.
20. Jewell JH, Buchert WI. Unilateral hereditary hydronephrosis: a report of four cases in three consecutive generations. J Urol 1962;88:129-136.
21. Izquierdo L, Porteous M, Paramo PG, Conner JM. Evidence for genetic heterogeneity in hereditary hydronephrosis caused by pelvi-ureteric junction obstruction, with one locus assigned to chromosome 6p. Hum Genet 1992;89:557-560.
22. Groener PM, Garcia E, Debeer P, Devriendt K, Fryns JP, Van de Ven WJ. Structure, sequence, and chromosome 19 localization of human USF2 and its rearrangement in a patient with multicystic renal dysplasia. Genomics 1996;38:141-148.
23. Noe HN, Wyatt RJ, Peeden JN, Rivas ML. The transmission of vesico-ureteral reflux from parent to child. J Urol 1992;148:1869-1871.
24. Hollowell JG, Greenfield SP. Screening siblings for vesico-ureteral reflux. J Urol 2002;168:2138-2141.
25. Feather SA, Malcolm S, Woolf AS, Wright V, Blaydon D, Reid CJ, et al. Primary nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1. Am J Hum Genet 2000;66:1420-1425.
26. Salonen R. The Meckel syndrome: clinicopathological findings in 67 patients. Am J Med Genet 1984;18:671-689.
27. Chen H, Yang SS, Gonzalez E, Fowler M, Al Saadi A. Short rib polydactyly syndrome, Majewski type. Am J Med Genet 1980;7:215-222.
28. Cideciyan D, Rodriguez MM, Haun RL, Abdenour GE, Bruce JH. New findings in short rib syndrome. Am J Med Genet 1993;46:255-259.
29. Fujimoto S, Yokochi K, Morikawa H, Nakano M, Shibata H, Togari H, Wada Y. Recurrent cerebral infarctions and del(10)(p14p15.1) de novo in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome. Am J Med Genet 1999;86:427-429.
30. Bilous RW, Murty G, Parkinson DB, Thakker RV, Coulthard MG, Burn J, et al. Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. N Engl J Med 1992;327:1069-1074.
31. Shaw NJ, Haigh D, Lealmann GT, Karbani G, Brocklebank JT, Dillon MJ. Autosomal recessive hypoparathyroidism with renal insufficiency and developmental delay. Arch Dis Child 1991;66:1191-1194.
32. Patau K, Smith DW, Therman E, Inhorn SL, Wagner HP. Multiple congenital anomaly caused by an extra autosome. Lancet 1960;275:790-793.
33. Moerman P, Fryns, van der Steen K, Kleczkowska A, Lauweryns J. The pathology of trisomy 13. A study of 12 cases. Hum Genet 1988;80:349-356.
34. Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, et al. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 1973;182:62-64.
35. Ulbright CE, Hodes ME, Ulbright TM. New syndrome: renal dysplasia, mesomelia, and radiohumeral fusion. Am J Med Genet 1984;17:667-668.
36. Schrander-Stumpel C, de Die-Smulders C, Fryns JP, da Costa J, Bouckaert P. Limb reduction defects and renal dysplasia: confirmation of a new, apparently lethal, autosomal recessive MCA syndrome. Am J Med Genet 1990;37:133-135.
37. Melnick M, Bixler D, Silk K, Yune H, Nance WE. Autosomal dominant branchiootorenal dysplasia. Birth Defects Original Article Series XI 1975;(5):121.
38. Kumar S, Marres HA, Cor WR, Cremers CW, Kimberling WJ. Autosomal-dominant branchio-otic (BO) syndrome is not allelic to the branchio-oto-renal (BOR) gene at 8q13. Am J Med Genet 1998;76:395-401.
39. Kumar S, Deffenbacher K, Marres HA, Cor WR, Cremers CW, Kimberling WJ. Genomewide search and genetic localization of a second gene associated with autosomal dominant branchio-oto-renal syndrome: clinical and genetic implications. Am J Hum Genet 2000;66:1715-1720.
40. Adra A, Cordero D, Mejides A, Yasin S, Salman F, O'Sullivan MJ. Caudal regression syndrome: etiopathogenesis, prenatal diagnosis, and perinatal management. Obstet Gynecol Surv 1994;49:508-516.
41. Pitera JE, Smith VV, Wolf AS, Milla PJ. Embryonic gut anomalies in a mouse model of retinoic acid-induced caudal regression syndrome. Am J Pathol 2001;159:2321-2329.
42. Gonzalez-Quintero VH, Tolaymat L, Martin D, Romaguera RL, Rodríguez MM, Izquierdo LA. Sonographic diagnosis of caudal regression in the first trimester of pregnancy. J Ultrasound Med 2002;21:1175-1178.
43. Chugh SS, Wallner EI, Kanwar YS. Renal development in high-glucose ambience and diabetic embryopathy. Semin Nephrol 2003;23:583-592.
44. Sadler TW, Hunter ES, Wynn RE, Phillips LS. Evidence of multifactorial origin of diabetes-induced embryopathies. Diabetes 1989;38:70-74.
45. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 2000;77:S26-S30.
46. Hiramatsu Y, Sekiguchi N, Hayashi M, Issihiki K, Yokota T, King GL, Loeken MR. Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy. Diabetes 2002;51:2804-2810.
47. Kaplan BS, Kaplan P, de Chadarevian JP, Jequier S, O'Regan S, Russo P. Variable expression of autosomal recessive polycystic kidney disease and congenital hepatic fibrosis within a family. Am J Med Genet 1988;29:639-647.
48. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002;30:259-269.
49. Pei Y. Molecular genetics of autosomal dominant polycystic kidney disease. Clin Invest Med, 2003;26:252-258.
50. Ibraghimov-Beskrovnaya O, Bukanov NO, Donohue LC, Dackowski WR, Klinger KW, Landes GM. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant gene, PKD1. Hum Molec Genet 2999;9:1641-1649.
51. Taylor CL, Jones KL, Jones MC, Kaplan GW. Incidence of renal anomalies in children prenatally exposed to ethanol. Pediatrics 1994;94:209-212.
52. Gage JC, Sulick KK. Pathogenesis of ethanol-induced hydronephrosis and hydroureter as demonstrated following in vivo exposure of mouse embryos. Teratology 1991;44:299-312.
53. Abu-Abed S, Dolle P, Metzger D, Beckett B, Chambon P, Petkovich M. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev 2001;15:226-240.
54. Rodriguez MM, Gómez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004;7:17-25.
55. Gordon I, Riccabona M. Investigating the newborn kidney: update on imagin technique. Semin Neonatol 2003;8:269-278.
56. De Carolis MP, Romagnoli C, de Santis M, Piersigilli F, Vento G, Caruso A. Is there significant improvement in neonatal outcome after treating pPROM mothers with ammo-infusion? Biol Neonate 2004;8:222-229.
57. Clark TJ, Martin WL, Divakaran TG, Whittle MJ, Kilby MD, Khan KS. Prenatal bladder drainage in the management of fetal lower urinary tract obstruction: a systematic review and meta-analysis. Obstet Gynecol 2003;102:367-382.
58. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulus MH, Xiao H, Merril CR, Wu A, Olde B, et al. Complementary DNA sequencing: "expressed sequence tags" and the Human Genome Project. Science 1991;252:1651-1656.
59. Alcorta DA, Prakash K, Waga I, Sasai H, Munger W, Jeannette JC, Falk RJ. Future molecular approaches to the diagnosis and treatment of glomerular disease. Semin Nephrol 2000:20-31.
60. Eraly SA, Blantz RC, Bhatnagar V, Nigam SK. Novel aspects of renal organic anion transporters. Curr Opin Nephrol Hypertens 2003;12:551-558.
61. Saino K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, et al. Glial-cell-line derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 1997;124:407-487.